Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,066,801,114
-$119,907,388 QoQ
Shares Held
10,899,700
-1.7% QoQ
Ownership
0.703%
of shares outstanding
% of Portfolio
3.05%
of 13F equity value
Holder Rank
#21
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AVIVA PLC holds $4,883,087,810 across 10 Drug Manufacturers - General names. AZN ranks #1 (42.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
10,899,700 | $2,066,801,114 | |
| 2 | LLY |
ELI LILLY & Co
|
718,261 | $861,503,863 | |
| 3 | JNJ |
Johnson & Johnson
|
2,162,709 | $549,263,204 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,264,106 | $419,437,621 | |
| 5 | ABBV |
AbbVie Inc.
|
1,664,656 | $418,894,035 | |
| 6 | AMGN |
Amgen Inc
|
471,664 | $170,798,967 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,183,858 | $149,568,619 | |
| 8 | PFE |
Pfizer Inc
|
4,977,327 | $119,854,034 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,066,801,114 | 10,899,700 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,186,708,502 | 11,087,661 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||